Specific binding agents to varicella-zoster virus and uses related thereto
AssigneeEmory University
InventorsRafi Ahmed, Nicole Sullivan
Life of this patent
Estimating the term…
Abstract
This disclosure relates to specific binding agents to varicella-zoster virus proteins or glycoproteins. In certain embodiments the specific binding agents are antibodies and binding fragments thereof disclosed herein. In certain embodiments, this disclosure relates to methods of treating or preventing a varicella-zoster infection comprising administering an effective amount of a specific binding agent disclosed herein to a subject in need thereof.
Claims8
A recombinant chimeric antibody or fragment comprising six complementarity determining regions (CDRs) of antibody RM-2D6,
- wherein the CDRs comprise three heavy chain CDRs, wherein heavy chain CDR 1 comprises the amino acid sequence of GFMFSSYG (SEQ ID NO:
- 3);
- CDR 2 comprises the amino acid sequence of VSHDGTND (SEQ ID NO:
- 4), and CDR 3 comprises the amino acid sequence of AKTSWARFLEWTFDY (SEQ ID NO:
- 1), and,
- wherein the CDRs comprise three light chain CDRs, wherein light chain CDR 1 comprises the amino acid sequence of QSINRY (SEQ ID NO:
- 5);
- light chain CDR2 comprises the amino acid sequence of GASS (SEQ ID NO:
- 6);
- and light chain CDR3 comprises the amino acid sequence of QQSHSTPT (SEQ ID NO:
- 2);
- and,
- wherein the antibody or fragment specifically binds a glycoprotein of varicella-zoster virus.
A recombinant chimeric antibody or fragment comprising six complementarity determining regions (CDRs) of antibody 302-1G9,
- wherein the CDRs comprise three heavy chain CDRs, wherein heavy chain CDR 1 comprises the amino acid sequence of GYTFSNYG (SEQ ID NO:
- 11);
- CDR 2 comprises the amino acid sequence of ISASNANT (SEQ ID NO:
- 12), and CDR 3 comprises the amino acid sequence of ARDRGGSLAMVVGLDH (SEQ ID NO:
- 9), and,
- wherein the CDRs comprise three light chain CDRs, wherein light chain CDR 1 comprises the amino acid sequence of QSIGGY (SEQ ID NO:
- 13);
- light chain CDR2 comprises the amino acid sequence of AAST (SEQ ID NO:
- 14);
- and light chain CDR3 comprises the amino acid sequence of QQCYSAELT (SEQ ID NO:
- 10);
- and,
- wherein the antibody or fragment specifically binds a glycoprotein of varicella-zoster virus.
Dependencies are inferred from the claim text.